Clinical Trials on Hallux Varus

Total 23623 results

National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC; Cooperative Clinical Trials in Pediatric Transplantation and other collaborators

Terminated

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

Kidney Transplant Recipients

United States
Ology Bioservices

Completed

Ross River Virus (RRV) Vaccine Study

Prophylaxis of Ross River Virus Infection

Australia
Janssen Sciences Ireland UC

Completed

Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.

Respiratory Syncytial Virus Infections

United Kingdom
Albert B. Sabin Vaccine Institute
Biomedical Advanced Research and Development Authority

Active, not recruiting

Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults

Marburg Virus Disease

Uganda, Kenya
BioCryst Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430

Marburg Virus Disease

United States
University Hospital, Strasbourg, France

Recruiting

Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUS (BKV-Allograf)

BK Virus Infection

France
Procare Health Iberia S.L.

Completed

Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV (PAPILOCAN)

HPV Infection | Lesion Cervix

Spain
Auro Vaccines LLC
PATH; Coalition for Epidemic Preparedness Innovations; Cincinnati Children's...

Completed

Safety and Immunogenicity of a Nipah Virus Vaccine

Nipah Virus Infection

United States
Montreal Heart Institute
National Heart, Lung, and Blood Institute (NHLBI); Bill and Melinda Gates Foundation and other collaborators

Terminated

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19)

Corona Virus Infection

Spain, United States, Canada, Brazil, Greece, South Africa
Merck Sharp & Dohme LLC

Completed

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

HPV Infections
GlaxoSmithKline

Completed

A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

Virus Diseases

China
Merck Sharp & Dohme LLC

Completed

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

HPV Infections
University Hospital, Strasbourg, France

Not yet recruiting

New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies (AcMBK)

BK Virus Infection

France
National Institute of Allergy and Infectious Diseases...
Moderna TX, Inc

Active, not recruiting

Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults

Nipah Virus Infection

United States
BlueSky Immunotherapies GmbH

Enrolling by invitation

BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

HPV Infection | Safety Issues

Austria
Chimerix

Completed

Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses

Double-stranded DNA Virus

United States
Procare Health Iberia S.L.
Adknoma Health Research

Completed

Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV. (PAPILOBS)

HPV Infection | Lesion Cervix

Spain
Kanazawa Medical University
Merck Sharp & Dohme LLC

Unknown

Changes in the Prevalence of Oncogenic HPV Types

Papillomavirus Infections | Papillomavirus Vaccines
National Institutes of Health Clinical Center (CC)

Completed

Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease

West Nile Virus

United States
AstraZeneca

Completed

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants (SENTINEL1)

Respiratory Syncytial Virus Hospitalizations

United States
Merck Sharp & Dohme LLC

Completed

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

HPV Infections
National Institute of Allergy and Infectious Diseases...

Completed

Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants

Human Parainfluenza Virus 2

United States
University of California, San Francisco

Completed

Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients

BK Virus Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Rabies | Rabies Virus

China
St. Jude Children's Research Hospital

Completed

Prospective Surveillance For Respiratory Virus Infections In Children Undergoing Hematopoietic Stem Cell Transplantation

Respiratory Virus Infections

United States
University of Alabama at Birmingham

Completed

A Study to Identify Markers in Blood and Tissue of HPV Clearance

HPV Infections

United States
Merck Sharp & Dohme LLC

Suspended

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

HPV Infections
Radboud University Medical Center

Terminated

Pharmacokinetics of Valacyclovir Oral Solution in Children (VALID2)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
National Institute of Allergy and Infectious Diseases...

Suspended

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Ebola Virus Disease

United States
Materno-Perinatal Hospital of the State of Mexico
Universidad Autonoma del Estado de Mexico

Completed

Genotypification and Predisposing Factors in Human Papilloma Virus Infection (HPV)

Intraepithelial Neoplasia
National Taiwan University Hospital

Unknown

The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test

Hepatitis B Virus Infection, Pregnancy

Taiwan
National Taiwan University Hospital

Unknown

Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus

Hepatitis B Virus Infection

Taiwan
Beijing Friendship Hospital

Not yet recruiting

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

Hemophagocytic Lymphohistiocytosis | Bowel Resection | Epstein-Barr Virus

China
Hospices Civils de Lyon

Completed

HBV Virions Bound Proteins

Hepatitis B Virus Infection

France
Abbott

Completed

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection (INSPIRA)

Respiratory Syncytial Virus Infection

Peru
Sophie Pils

Completed

HPV Prevalence in Transpersons - a Prospective Study

Transsexualism | Papillomavirus Infection

Austria, Slovenia
Merck Sharp & Dohme LLC

Completed

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

Varicella

Russian Federation
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Varicella

United States
Merck Sharp & Dohme LLC

Completed

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

Varicella
MedImmune LLC

Completed

A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants (MEDI8897 1b)

Respiratory Syncytial Virus

United States, South Africa, Chile
MRC/UVRI and LSHTM Uganda Research Unit
Ministry of Health, Uganda

Recruiting

Addressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central Uganda (Ebola+D)

Ebola Virus Disease

Uganda
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Not yet recruiting

Pilot Study Evaluating the Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Ebola Virus Disease

Guinea
ANRS, Emerging Infectious Diseases

Not yet recruiting

Prophylaxis Vaccine Antibodies Ebola (PROVAE)

Ebola Virus Disease

Guinea
National Institute of Allergy and Infectious Diseases...
London School of Hygiene and Tropical Medicine; Institut National de la Santé... and other collaborators

Active, not recruiting

Partnership for Research on Ebola VACcinations (PREVAC)

Ebola Virus Disease

Guinea, Liberia, Mali, Sierra Leone
Janssen Vaccines & Prevention B.V.
London School of Hygiene and Tropical Medicine; Institut National de la Santé... and other collaborators

Completed

A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants

Ebola Virus Disease

Guinea, Sierra Leone
London School of Hygiene and Tropical Medicine
Institut National de la Santé Et de la Recherche Médicale, France; Universiteit... and other collaborators

Completed

EBOVAC-Salone Extension

Ebola Virus Disease

Sierra Leone
Universiteit Antwerpen
Johnson & Johnson; University of Kinshasa; Innovative Medicines Initiative; Coalition... and other collaborators

Completed

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola (EBOVAC3DRC)

Ebola Virus Disease

Congo, The Democratic Republic of the
National Institute of Allergy and Infectious Diseases...

Completed

Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up

Ebola Virus Disease

United States, Liberia
Janssen Vaccines & Prevention B.V.
London School of Hygiene and Tropical Medicine; Institut National de la Santé... and other collaborators

Completed

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo (EBOVAC-Salone)

Ebola Virus Disease

Sierra Leone
Institut National de la Santé Et de la Recherche...
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique... and other collaborators

Completed

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)

Ebola Virus Disease

Congo, The Democratic Republic of the

Clinical Trials on Hallux Varus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations